Xue Shan
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Immunotherapy and Immune Responses, Cell Adhesion Molecules Research, MicroRNA in disease regulation, Nanoplatforms for cancer theranostics
Most-Cited Works
- → miR-26b Promotes Granulosa Cell Apoptosis by Targeting ATM during Follicular Atresia in Porcine Ovary(2012)159 cited
- → Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus(2019)95 cited
- → An elegant nitroreductase responsive fluorescent probe for selective detection of pathogenic Listeria in vitro and in vivo(2019)25 cited
- → The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer(2019)21 cited
- → Stimuli-responsive combination therapy of cisplatin and Nrf2 siRNA for improving antitumor treatment of osteosarcoma(2020)20 cited
- → Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma(2019)20 cited
- → Integrin αvβ3-Specific Hydrocyanine for Cooperative Targeting of Glioblastoma with High Sensitivity and Specificity(2019)17 cited
- → A stimuli-responsive combination therapy for recovering p53-inactivation associated drug resistance(2019)15 cited
- → A sensitive and fast responsive fluorescent probe for imaging hypoxic tumors(2018)14 cited
- → The Role of the lncRNA-LRCF in Propofol-Induced Oligodendrocyte Damage in Neonatal Mouse(2021)12 cited